USA Today – The path of prescription drugs from the factory to the patient is complicated. Here, Julie Appleby of Kaiser Health News explains how money flows through the system and contributes to the cost of a 30-day supply of a hypothetical brand-name medicine.
Pharmacy-benefit managers and the rebates they command come in for criticism by pharmaceutical executives Wall Street Journal – As U.S. drug prices rise, drugmakers are playing down their role, instead heaping blame on the middlemen who help determine how medicines are priced. Some of the sharpest criticism has come from drug-industry executives who have been grilled […]
CANTONMENT, Fla. (WEARTV – ABC3) — Many family pharmacists are outraged and worried over a pending change in Medicaid policy. Molina Healthcare, one of the two Medicaid HMO providers in the area, will no longer cover prescriptions from several independent northwest Florida pharmacies in their new network which kicks in October 1. The bigger pharmacies […]
The Cedar Rapids Gazette – By Brandon Gerleman As a third-year pharmacy student, I see the need for accessibility to quality health care services in Iowa. Many Iowans live in rural and underserved areas too far from quality health care. Roughly 44 percent of Iowans fall into this category. Many residents have to travel longer […]
Here is a link to the submission Dear Mr. Slavitt and Secretary Burwell, As the national board chairman of the Pharmacy Choice & Access Now (PCAN) coalition, I am writing to you to urge CMS to delay the effective date of CMS-2345-FC, the Medicaid Final Rule on Covered Outpatient Drugs. PCAN is a coalition comprised […]